What is your management approach for CAR-T induced motor neurologic deficits (cyclophosphamide/IVIG/Steroids, etc) and any prophylactic approach to an early, rapid rise in absolute lymphocyte count post CAR-T infusion?  

Specifically, this seems to be a question around cilta-cel. There has been some recent guidance to consider pre-emptively starting dexamethasone if the absolute lymphocyte count rises above 3,000 in the period following CAR T administration. This partially stems from the observation that many of th...